Skip to content

Clinical evaluation of T-AYU-HM Premium in sickle cell anemia patients: A Retrospective Study

Clinical assessment of anti sickling herbo- mineral formulation T-AYU-HM Premium on sickle cell anemia at Dhanvantari Clinic OPD patients: A Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040601
Enrollment
200
Registered
2022-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D578- Other sickle-cell disorders

Interventions

None listed

Sponsors

Dhanvantari Clinic Ayurveda Health Care Research Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients were treated with T-AYU-HM Premium for sickle cell anemia at Dhanvantari Clinic between 1st January 2018 to 31st December 2020. 2.Patients with a diagnosis of Sickle Cell Anemia (SCT/SCD) 3.Patients = 5 years of age 4. Patient’s = 3 months of follow-up data available from the first treatment at the center. 5. Patient’s visited OPD of clinic regularly on scheduled appointment date 6. Patients who were hospitalized for crisis condition.

Exclusion criteria

Exclusion criteria: 1.Patients who were taking other medicines for anemia 2. Pregnant and lactating women. 3. Patient’s laboratory parameters data are not available. 4. Patients follow-up is irregular

Design outcomes

Primary

MeasureTime frame
1.Effect of Treatment on Complete blood counts 2. Effect of Treatment on patients Symptoms Timepoint: At Baseline day 0, 30th, 90th and 120 days of treatment

Secondary

MeasureTime frame
1.Effect of treatment on Number of times patient was hospitalized during the study period 2.Effect of treatment on Number of pain crisis episodes during treatment period 3.Effect of treatment on No. of times blood transfusions required during observation period Timepoint: At Baseline day 0, 30th , 90th, 120th day of treatment

Countries

India

Contacts

Public ContactAtul Desai

Dhanvantari Clinic, Ayurveda health care and research

dratuldesai@rediffmail.com9879031621

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026